RxDoctor Payments Data

Abhishek Reddy, DO

Physical Medicine & Rehabilitation · Indianapolis, INNPI 1891091104

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 32.6% of the total. Reporting peaked in 2019 at $656 and has fallen 78.5% since, to $141 in 2025.

$2,364in general payments, 2019–2025

Across 57 payments — averaging $41.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$771
  • Nevro Corp.$162
  • GRT US Holding, Inc.$149
  • Medtronic$143
  • Centinel Spine, LLC$140
  • Microtransponder, Inc.$131
  • plus $868 from 14 others

What the payments were for

  • Food & beverage$2,364100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,364 in reported general payments places this provider in the 80th percentile of 140 physical medicine & rehabilitation providers in Indiana.

See all physical medicine & rehabilitation providers in Indiana

Medicare billing

Part B allowed, 2024
$189,389
Medicare patients
677
Services billed
2,255

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin265$4,856
Buprenorphine13$3,903
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen179$3,347
Meloxicam42$2,310
Pregabalin90$2,205
Tramadol Hcl145$1,324
Lidocaine15$1,314
Methocarbamol64$1,145
Baclofen73$1,044
Oxycodone Hcl40$859
Tizanidine Hcl42$835
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen23$508
Duloxetine Hcl30$459
Methylprednisolone31$163
Cyclobenzaprine Hcl19$66

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →